Table 3. Community screening for PSGN cases in a First Nations community in northwestern Ontario, November 27 to December 3, 2017.
| Characteristics | Screened population | Total | |||
|---|---|---|---|---|---|
| Children | Adults | ||||
| Total of participants | Contacts | Non-contacts | Contacts | ||
| Eligible for screening | 224 | 17 | 207 | 19 | 243 |
| Screened | 212 | 16 | 196 | 19 | 231 |
| Refused screening | 12 | 1 | 11 | 0 | 12 |
| New cases | 1 | 1 | 0 | 0 | 0 |
| Treated | 20 | 16a | 4b | 2b | 22 |
| Penicillin G | 11 | 10 | 1 | 2 | 13 |
| Cephalexin | 10 | 7 | 3 | 0 | 10 |
Abbreviation: PSGN, post-streptococcal glomerulonephritis
a Three with skin sores
b With skin sores